Cargando…
Gender-affirming hormone therapy in cystic fibrosis – A case of new Pseudomonas infection
BACKGROUND: Little is known about the impact of hormone therapy on transgender youth with Cystic Fibrosis (CF). This case report describes an 18-year-old affirmed female with CF who was treated with hormone therapy associated in timing with new growth of Pseudomonas aeruginosa in her sputum culture....
Autores principales: | Shaffer, L., Bozkanat, K., Lau, M., Sharma, P., Sathe, M., Lopez, X., Jain, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841348/ https://www.ncbi.nlm.nih.gov/pubmed/33537203 http://dx.doi.org/10.1016/j.rmcr.2021.101353 |
Ejemplares similares
-
Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018) -
Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022) -
100. Patterns of Perioperative Hormone Therapy for Gender-affirming Surgery
por: Hung, Ya-Ching, et al.
Publicado: (2023) -
The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
por: Schutte, Moya H., et al.
Publicado: (2022) -
Localized Rhabdomyolysis Associated With Testosterone Enanthate for Gender-Affirming Hormonal Therapy
por: Reddy, Rashmi, et al.
Publicado: (2022)